Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 1,500 | 6,200 | 500 | 7,143 | 1,120 |
| Gross Profit | 1,500 | 6,200 | 500 | 7,143 | 1,120 |
| Operating Expenses | 28,481 | 31,066 | 52,192 | 94,507 | 96,586 |
| Operating Income | -26,981 | -24,866 | -51,692 | -87,364 | -95,466 |
| Interest Expense | 0 | 0 | 2,659 | 4,280 | 4,199 |
| Other Income | 2,010 | 15,161 | 46,629 | -20,833 | 1,629 |
| Pre-tax Income | -24,971 | -9,705 | -7,722 | -112,477 | -98,036 |
| Income Tax | -2 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -24,969 | -9,705 | -7,722 | -112,477 | -98,036 |
| Net Income | $-24,969 | $-9,705 | $-7,722 | $-112,477 | $-98,036 |
| EPS Basic Total Ops | -0.81 | -0.84 | -1.34 | -24.01 | -24.37 |
| EPS Basic Continuous Ops | -0.81 | -0.84 | -1.34 | -24.01 | -24.37 |
| EPS Diluted Total Ops | -0.81 | -0.84 | -1.34 | -24.01 | -24.37 |
| EPS Diluted Continuous Ops | -0.81 | -0.84 | -1.34 | -24.01 | -24.37 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.88 | -3.66 | -19.91 | -24.40 |
| EBITDA(a) | $-26,970 | $-24,761 | $-49,670 | $-79,334 | $-87,788 |